Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
Academy for Sickle Cell and Thalassaemia (ASCAT 2026) 7 - 10 October 2026

Transfusion-dependent SCD: management challenges and emerging phase 2 evidence for etavopivat

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Sickle Cell Disease
Congress oral presentation
Etavopivat